St. Johns Investment Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-500
Closed -$35K 179
2018
Q2
$35K Sell
500
-4,541
-90% -$321K 0.03% 114
2018
Q1
$380K Buy
5,041
+33
+0.7% +$2.62K 0.29% 73
2017
Q4
$359K Buy
5,008
+221
+5% +$16.8K 0.26% 74
2017
Q3
$388K Sell
4,787
-249
-5% -$19K 0.28% 75
2017
Q2
$356K Buy
5,036
+1,214
+32% +$80.8K 0.27% 75
2017
Q1
$260K Buy
3,822
+281
+8% +$19.8K 0.21% 77
2016
Q4
$254K Sell
3,541
-5,931
-63% -$441K 0.21% 77
2016
Q3
$749K Buy
9,472
+755
+9% +$61.3K 0.63% 60
2016
Q2
$727K Buy
8,717
+380
+5% +$33.7K 0.66% 57
2016
Q1
$766K Buy
8,337
+575
+7% +$51.9K 0.68% 56
2015
Q4
$785K Buy
7,762
+105
+1% +$10.9K 0.71% 50
2015
Q3
$752K Buy
7,657
+1,167
+18% +$130K 0.71% 53
2015
Q2
$760K Buy
6,490
+345
+6% +$37.7K 0.65% 57
2015
Q1
$603K Buy
6,145
+3,305
+116% +$336K 0.53% 64
2014
Q4
$268K Buy
2,840
+2,657
+1,452% +$275K 0.23% 72
2014
Q3
$19K Buy
+183
New +$17.9K 0.02% 96

Other funds holding GILD

St. Johns Investment Management's GILD Position: Q3 2018 in Review

St. Johns Investment Management sold out of Gilead Sciences (GILD) in Q3 2018, closing a stake of 500 shares — an estimated $35K sold.

St. Johns Investment Management first reported a position in GILD in Q3 2014 and held it in 16 quarters. The position peaked at $785K in Q4 2015. 1,527 funds tracked by Wall St. Rank hold GILD as of Q3 2018.

  • St. Johns Investment Management reported no remaining Gilead Sciences position as of Q3 2018 after selling out during the quarter.
  • St. Johns Investment Management sold 500 Gilead Sciences shares in Q3 2018, an estimated $35K.
  • St. Johns Investment Management first reported a position in Gilead Sciences in Q3 2014 and held it in 16 quarters.
  • St. Johns Investment Management's Gilead Sciences position peaked at $785K in Q4 2015.
  • 1,527 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2018.

Based on St. Johns Investment Management's 13F filing for Q3 2018, filed 22 Oct 2018.